EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Challenges in Chronic Myeloid Leukemia Management in South America

Katia B Pagnano, Ana Ines Varela, Carolina Pavlovsky, Israel Bendit, Vaneuza A M Funke, Virginia Abello Polo

Current Hematologic Malignancy Reports · 2021-10 · 16 (5) · 440-447

DOI: 10.1007/s11899-021-00654-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Hematologic Malignancy Reports, online erschienen am 15.10.2021. Verfasst von Katia B Pagnano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Hematologia E Hemoterapia, Universidade Estadual de Campinas, Campinas, SP, Brazil. kborgia@unicamp.br. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: Chronic myeloid leukemia (CML) management in developing countries has improved in the last years, but the availability of therapeutic resources, monitoring, reimbursement, and financial issues may be a challenge and interfere with the best practices and results of CML treatment. This review points out the main challenges in CML management in South America. RECENT FINDINGS: In this review, we describe the access to tyrosine kinase inhibitors and monitoring in different countries of South America. We also address the ongoing discontinuation trials, the progress, and limitations of hematopoietic stem cell transplantation in the last years. There are still many challenges for achieving the best outcomes for CML patients in South America. The continuous efforts to provide continuous education, access to tyrosine kinase inhibitors, and monitoring, providing reference centers for CML management and hematopoietic stem cell transplantation may improve patients' outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsDisease ManagementHematopoietic Stem Cell TransplantationHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsSouth America

Stichwörter der Autor:innen

Chronic myeloid leukemiaHematopoietic stem cell transplantationManagementMonitoringTreatment-free remissionTyrosine kinase inhibitors

Substanzen

Antineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Centro de Hematologia E Hemoterapia, Universidade Estadual de Campinas, Campinas, SP, Brazil. kborgia@unicamp.br.
  • Hospital J.M. Ramos Mejía, Sanatorio Las Lomas, Buenos Aires, Argentina.
  • FUNDALEU, Buenos Aires, Argentina.
  • Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM/31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São…
  • Complexo Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
  • Facultad de Medicina, Fundación Universitaria de Ciencias de La Salud. Servicio de Hematología, Hospital de San José. Servicio de Hematología, Clínica del Country, Bogotá, Colombia.

Zitieren

APA

Pagnano, K. B., Varela, A. I., Pavlovsky, C., Bendit, I., Funke, V. A. M., & Polo, V. A. (2021). Challenges in Chronic Myeloid Leukemia Management in South America. Current Hematologic Malignancy Reports, 16(5), 440-447. https://doi.org/10.1007/s11899-021-00654-0

Vancouver

Pagnano KB, Varela AI, Pavlovsky C, Bendit I, Funke VAM, Polo VA. Challenges in Chronic Myeloid Leukemia Management in South America. Current Hematologic Malignancy Reports. 2021;16(5):440-447. doi:10.1007/s11899-021-00654-0

BibTeX
@article{Pagnano2021,
  author = {Pagnano, Katia B and Varela, Ana Ines and Pavlovsky, Carolina and Bendit, Israel and Funke, Vaneuza A M and Polo, Virginia Abello},
  title = {Challenges in Chronic Myeloid Leukemia Management in South America},
  journal = {Current Hematologic Malignancy Reports},
  year = {2021},
  volume = {16},
  number = {5},
  pages = {440--447},
  doi = {10.1007/s11899-021-00654-0}
}
Kostenlos starten →